A recent meta-analysis summarized 54 studies and suggested that peripheral blood inflammatory markers (CRP, TNF and IL-6) were significantly related to cancer-related DepS and might be helpful for management of DepS in the cancer patients [43]. The gene discussed is IL6; the disease is cancer.